This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

UL Acquires Wiklund Research & Design, Adds Human Factors Engineering Expertise To Life & Health Offerings

NORTHBROOK, Ill. and CONCORD, Mass., Nov. 9, 2012 /PRNewswire/ -- UL, a world leader in advancing safety, announced today the acquisition of Wiklund Research & Design, Inc., one of North America's leading providers of human factors engineering (HFE) to the life and health sector.  The addition positions UL to fully support medical and diagnostic device manufacturers as a single, trusted source of conformance and certification services across the entire product lifecycle.

Wiklund Research & Design provides user research, design support, evaluation and training services to assure medical device use-safety and usability.  Many leading life and health product manufacturers rely upon Wiklund Research & Design's usability testing services to verify compliance to North American and European regulatory standards.

"Joining UL is a natural fit for our team, and a significant benefit for our customers," said Michael Wiklund, founder and president of Wiklund Research & Design.  "We are now part of a wider breadth of medical and diagnostic device services, a deeper well of expertise, and the world's most trusted name in safety." 

"With the rapid pace of innovation in the life and health industry, manufacturers need a trusted partner to provide global market access and conformance seamlessly throughout the lifecycle of product development," said Hiroshi Yamaki, president of UL's Life & Health business unit.  "Human factors engineering was a missing piece for us, and in Wiklund Research & Design, we added one of the industry's market and thought leaders."

Wiklund Research & Design complements UL's existing file construction, analytical testing, risk management, and quality system offerings to round out a robust line of testing, conformance delivery, design support and advisory services for medical and diagnostic device manufacturers. Wiklund Research & Design is UL's third life and health conformance-related acquisition in 14 months, when MDT and MDRS were acquired in August 2011.

Michael Wiklund will continue to manage UL's human factors engineering operations. The business will remain headquartered in the Boston area.

About Wiklund Research & Design Formed as an independent practice in 2004 and incorporated in 2005, Wiklund Research & Design, Inc. is a usability testing laboratory and user interface development advisory firm that helps clients develop safe, usable, and satisfying products. Wiklund Research & Design offers a wide range of human factors-related research, analysis, design support, and usability testing services. Additional information about Wiklund Research & Design may be found at

About UL UL is a premier global independent safety science company with more than 118 years of history.  Employing more than 10,000 professionals in over 100 countries, UL has five distinct business units -- Product Safety, Environment, Life & Health, Knowledge Services, and Verification Services – to meet the expanding needs of our customers and to deliver on our public safety mission.  Additional information about UL may be found at


Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs